Saccharomyces boulardii in helicobacter pylori eradication in children: A randomized trial from Iran

Iranian Journal of Pediatrics

Volumn 26, Issue 1, 2016, Pages

  Namkin, Kokab ^a   Zardast, Mahmood ^a   Basirinejad, Fatemeh ^a  

^a BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Helicobacter pylori; Helicobacter pylori stool antigen; Probiotic; Saccharomyces boulardii

Indexed keywords

BACTERIAL ANTIGEN; HELICOBACTER PYLORI ANTIGEN; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ARTICLE; ASYMPTOMATIC INFECTION; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; FEMALE; FEVER; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IRAN; LOSS OF APPETITE; MALE; NAUSEA AND VOMITING; PRIMARY SCHOOL; RANDOMIZED CONTROLLED TRIAL; SACCHAROMYCES BOULARDII; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 84957594114     PISSN: 20082142     EISSN: 20082150     Source Type: Journal    
DOI: 10.5812/ijp.3768     Document Type: Article

References (27)

1. Khodadad A, Farahmand F, Najafi M, Shoaran M. Probiotics for the treatment of pediatric Helicobacter pylori infection: a randomized double blind clinical trial. Iran J Pediatr. 2013;23(1):79–84. [PubMed: 23446685]
2. Mehling H, Busjahn A. Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass) as a new approach to Helicobacter pylori control in humans. Nutrients. 2013;5(8):3062–73. doi: 10.3390/nu5083062. [PubMed: 23917169]
3. Vitor JM, Vale FF. Alternative therapies for Helicobacter pylori: probiotics and phytomedicine. FEMS Immunol Med Microbiol. 2011;63(2):153–64. doi: 10.1111/j.1574-695X.2011.00865.x. [PubMed: 22077218]
4. Ruggiero P. Use of probiotics in the fight against Helicobacter pylori. World J Gastrointest Pathophysiol. 2014;5(4):384–91. doi: 10.4291/wjgp.v5.i4.384. [PubMed: 25400981]
5. Horvitz G, Gold BD. Gastroduodenal diseases of childhood. Curr Opin Gastroenterol. 2006;22(6):632–40. doi: 10.1097/01.mog.0000245534.58389.f3. [PubMed: 17053441]
6. Boonyaritichaikij S, Kuwabara K, Nagano J, Kobayashi K, Koga Y. Long-term administration of probiotics to asymptomatic pre-school children for either the eradication or the prevention of Helicobacter pylori infection. Helicobacter. 2009;14(3):202–7. doi: 10.1111/j.1523-5378.2009.00675.x. [PubMed: 19702850]
7. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–9. doi: 10.1056/NEJMoa001999. [PubMed: 11556297]
8. Lionetti E, Indrio F, Pavone L, Borrelli G, Cavallo L, Francavilla R. Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature. Helicobacter. 2010;15(2):79–87. doi: 10.1111/j.1523-5378.2009.00743.x. [PubMed: 20402810]
9. Akcam M, Elmas O, Yilmaz A, Caglar S, Artan R, Gelen T, et al. Myeloperoxidase, xanthine oxidase and superoxide dismutase in the gastric mucosa of Helicobacter pylori positive and negative pediatric patients. Mol Cell Biochem. 2006;290(1-2):125–30. doi: 10.1007/s11010-006-9176-9. [PubMed: 16758302]
10. Iranikhah A, Ghadir MR, Sarkeshikian S, Saneian H, Heiari A, Mahvari M. Stool antigen tests for the detection of Helicobacter pylori in children. Iran J Pediatr. 2013;23(2):138–42. [PubMed: 23724172]
11. Sethi A, Chaudhuri M, Kelly L, Hopman W. Prevalence of Helicobacter pylori in a First Nations population in northwestern Ontario. Can Fam Physician. 2013;59(4):e182–7. [PubMed: 23585621]
12. Magista AM, Ierardi E, Castellaneta S, Miniello VL, Lionetti E, Francavilla A, et al. Helicobacter pylori status and symptom assessment two years after eradication in pediatric patients from a high prevalence area. J Pediatr Gastroenterol Nutr. 2005;40(3):312–8. [PubMed: 15735485]
13. Elitsur Y, Yahav J. Helicobacter pylori infection in pediatrics. Helicobacter. 2005;10 Suppl 1:47–53. doi: 10.1111/j.1523-5378.2005.00332.x. [PubMed: 16178971]
14. Garcia CA, Henriquez AP, Retamal RC, Pineda CS, Delgado Sen C, Gonzalez CC. [Probiotic properties of Lactobacillus spp isolated from gastric biopsies of Helicobacter pylori infected and non-infected individuals]. Rev Med Chil. 2009;137(3):369–76. [PubMed: 19621178]
15. Gotteland M, Brunser O, Cruchet S. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment Pharmacol Ther. 2006;23(8):1077–86. doi: 10.1111/j.1365-2036.2006.02868.x. [PubMed: 16611267]
16. Dinleyici EC, Kara A, Ozen M, Vandenplas Y. Saccharomyces boulardii CNCM I-745 in different clinical conditions. Expert Opin Biol Ther. 2014;14(11):1593-609. doi: 10.1517/14712598.2014.937419. [PubMed: 24995675]
17. Riaz M, Alam S, Malik A, Ali SM. Efficacy and safety of Saccharomyces boulardii in acute childhood diarrhea: a double blind randomised controlled trial. Indian J Pediatr. 2012;79(4):478–82. doi: 10.1007/s12098-011-0573-z. [PubMed: 21997865]
18. Hurduc V, Plesca D, Dragomir D, Sajin M, Vandenplas Y. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. Acta Paediatr. 2009;98(1):127–31. doi: 10.1111/j.1651-2227.2008.00977.x. [PubMed: 18681892]
19. Patel A, Shah N, Prajapati JB. Clinical application of probiotics in the treatment of Helicobacter pylori infection--a brief review. J Microbiol Immunol Infect. 2014;47(5):429–37. doi: 10.1016/j. jmii.2013.03.010. [PubMed: 23757373]
20. Namakin K. Prevalence of Helicobacter Pylori Infection in Asymptomatic Children in Birjand, Eastern Iran. Int J Pediatr. 2014;2(4.2):55-63.
21. Tepes B, O'Connor A, Gisbert JP, O'Morain C. Treatment of Helicobacter pylori infection 2012. Helicobacter. 2012;17 Suppl 1:36–42. doi: 10.1111/j.1523-5378.2012.00981.x. [PubMed: 22958154]
22. Federico A, Gravina AG, Miranda A, Loguercio C, Romano M. Eradication of Helicobacter pylori infection: which regimen first? World J Gastroenterol. 2014;20(3):665–72. doi: 10.3748/wjg.v20. i3.665. [PubMed: 24574740]
23. Lesbros-Pantoflickova D, Corthésy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr. 137:812–8.
24. Bin Z, Ya-Zheng X, Zhao-Hui D, Bo C, Li-Rong J, Vandenplas Y. The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children. Pediatr Gastroenterol Hepatol Nutr. 2015;18(1):17–22. doi: 10.5223/pghn.2015.18.1.17. [PubMed: 25866729]
25. Wang YH, Huang Y. Effect of Lactobacillus acidophilus and Bifidobacterium bifidum supplementation to standard triple therapy on Helicobacter pylori eradication and dynamic changes in intestinal flora. World J Microbiol Biotechnol. 2014;30(3):847–53. doi: 10.1007/s11274-013-1490-2. [PubMed: 24233772]
26. Akcam M, Koca T, Salman H, Karahan N. The effects of probiotics on treatment of Helicobacter pylori eradication in children. Saudi Med J. 2015;36(3):286–90. doi: 10.15537/smj.2015.3.10124. [PubMed: 25737169]
27. Szajewska H, Horvath A, Kolodziej M. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 2015;41(12):1237–45. doi: 10.1111/apt.13214.[PubMed: 25898944]